Log In
|
Sign Up
Analytics Tools
Stock Screener
Strategy Backtester
Stock Quote
Stock Chart
Watch Lists
Portfolio Tracker
Trade Alert
Crypto Screener
Crypto Backtest
Correlation
Quick Screens
Moving Averages
Oscillators
Trend Indicators
Line Studies
Chart Patterns
Channels
Volatility
Relative Strength
Financial Strength
Ichimoku
Price Action
Volume
Fundamental Data
Financial Metrics
To Industry Ratios
Dividend
In the Spotlight
Market Breadth
Cryptocurrency
Fund Screens
Intrinsic Value
Earnings Growth
Solid Dividends
Dogs of the Dow
Growth Leaders
Help
Help Topics
FAQ
What's New
Education
Articles
Contact Us
Get
Iovance Biotherapeutics Inc
MIL • Healthcare • Biotechnology • Quote as of 05/12/2026
Company Profile
Industry
Biotechnology
Sector
Healthcare
Exchange
MIL
Market Capitalization
1,513.64 mln
Float
383 mln
Earnings Date
05/07/2026
Piotroski F-Score
4
/ 9
Borderline
Beneish M-Score
-2.45
Borderline
Relative Strength
71
/ 100
Outperforming
Debt / Equity
0.07
Debt-free
ROE
-53.84
Deeply negative
Dividend Yield
0.00%
No dividend
Key Fundamentals
EPS
-0.93
ROE
-53.84
RPS
0.64
ROIC
-80.35
ROA
-41.87
EBITDA, mln
-309
EV / EBITDA
-3.80
EV / EBIT
-3.35
Revenue, mln
229
EV / Revenue
5.06
Financial Strength
Altman Z-Score
-0.57
Piotroski F-Score
4
/ 9
Beneish M-Score
-2.45
Price Performance & Relative Strength
Period
Price Performance
Relative Strength
1 Week
6.94%
86
/ 100
1 Month
-0.65%
37
/ 100
2 Months
44.6%
96
/ 100
Disclaimer
-
Privacy Policy
-
Terms Of Service
-
Cookie Use Policy
-
FAQ
-
Contact Us
